Kohjin Bio Co., Ltd.

Kohjin Bio Co., Ltd.

Share · JP3283630006 (XTKS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Kohjin Bio Co., Ltd.
No Price
Closing Price XTKS 28.04.2026: 1.430,00 JPY
28.04.2026 06:30
Current Prices from Kohjin Bio Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XTKS: Tokyo
Tokyo
177A.T
JPY
28.04.2026 06:30
1.430,00 JPY
86,00 JPY
+6,40 %
Share Float & Liquidity
Free Float 30,19 %
Shares Float 1,54 M
Shares Outstanding 5,11 M
Company Profile for Kohjin Bio Co., Ltd. Share
Kohjin Bio Co., Ltd. manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics. The company offers tissue culture mediums for virus and recombinant protein production, hybridoma, human lymphocyte culture, and insect cell lines; gas permeable cell culture bags and other materials; cryopreservation agent of cells; medium supplements; normal human cells; normal human cell mediums; ES cell mediums; in-vitro fertilization and early embryo culture kits; and other culture and related products, such as supplements, cell separation solutions, physiological salt solutions, and research reagents. The company also offers clinical microbiology culture mediums for gram positive cocci, gram negative bacteria, and susceptibility testing; general differential, anaerobic growth, and fungal mediums; tube mediums for confirmation and expansion; microbiology culture mediums for food, such as mediums for sterilization test, E. coli and coliform bacteria, staphylococcus spp., bacillus cereus, and vibrio parahaemolyticus; culture mediums for determining total viable cell count; and campylobacter and fungal mediums. In addition, the company offers normal human blood, serum, and plasma; pathological human serum; preserved animal blood; defibrinated and hemolyzed animal blood; animal serum and plasma; and other custom-designed products, such as eagle medium. Further, the company engages in the production and sale of laboratory animal, sale of medical equipment, trust of animal immunization and antibody preparation, and import and export of products and raw materials. The company was formerly known as Kohjin Co.,Ltd and changed its name to Kohjin Bio Co., Ltd. in 1989. The company was incorporated in 1981 and is based in Sakado, Japan.

Company Data

Name Kohjin Bio Co., Ltd.
Company Kohjin Bio Co., Ltd.
Website https://www.kohjin-bio.jp
Primary Exchange XTKS Tokyo
ISIN JP3283630006
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Takahito Nakamura
Market Capitalization 7 Mrd.
Country Japan
Currency JPY
Employees 0,2 T
Address 5-1-3, 350-0214 Sakado
IPO Date 2024-04-25
Dividends from 'Kohjin Bio Co., Ltd.'
Ex-Date Dividend per Share
30.03.2026 7,97 JPY
28.03.2025 24,00 JPY

Ticker Symbols

Name Symbol
Tokyo 177A.T
More Shares
Investors who hold Kohjin Bio Co., Ltd. also have the following shares in their portfolio:
EKSPORTFINANS ASA ACC CALL NTS 30/09/2041
EKSPORTFINANS ASA ACC CALL NTS 30/09/2041 Bond
ZUER.VER.GES 22/29 MTN
ZUER.VER.GES 22/29 MTN Bond